Alievio, Inc. designs, develops, and manufactures ophthalmic medical device for glaucoma patients. The company offers a novel device, Sollevio, which provides noninvasive titration of postoperative intraocular pressure (IOP) for the treatment of refractory glaucoma. Alievio, Inc. was formerly known as Camras Vision, Inc. and changed its name to Alievio, Inc. in June 2019. The company was incorporated in 2010 and is based in Research Triangle Park, North Carolina.